Contribution: Industrial Research Assistance Program – Contributions to Firms
PulseMedica Corp.
$225,000.00
Bench and Preclinical Study, Prototyping, Regulatory Study Design, and Pilots
FY 2025-26 · 2025-08-01
Summary
PulseMedica is advancing its floater treatment system (SVO-Tx), a 3D image-guided femtosecond laser device for the non-invasive treatment of symptomatic vitreous opacities (SVOs or eye floaters). This project will complete preclinical laser safety validation, system performance verification, and assembly finalization, along with certification of two clinic-ready prototypes. It will also support development of clinical protocols and regulatory documentation in preparation for a First-in-Human (FIH) study, to follow beyond this project’s scope.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
776889289
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2026-06-30
Agreement Number
1034494
Agreement Start Date
2025-08-01
Agreement Title
Bench and Preclinical Study, Prototyping, Regulatory Study Design, and Pilots
Agreement Title (French)
Études au banc et précliniques, prototypage, conception d’études réglementaires et projets pilotes
Agreement Type
Contribution
Agreement Value
$225,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
PulseMedica is advancing its floater treatment system (SVO-Tx), a 3D image-guided femtosecond laser device for the non-invasive treatment of symptomatic vitreous opacities (SVOs or eye floaters). This project will complete preclinical laser safety validation, system performance verification, and assembly finalization, along with certification of two clinic-ready prototypes. It will also support development of clinical protocols and regulatory documentation in preparation for a First-in-Human (FIH) study, to follow beyond this project’s scope.
Description (French)
PulseMedica fait progresser son système de traitement des flotteurs (SVO-Tx), un dispositif laser femtoseconde guidé par l’image 3D pour le traitement non invasif des opacités vitréennes symptomatiques (SVO ou flotteurs oculaires). Ce projet permettra d’achever la validation préclinique de la sécurité du laser, la vérification des performances du système et la finalisation de l’assemblage, ainsi que la certification de deux prototypes prêts à l’emploi. Il soutiendra également l’élaboration de protocoles cliniques et de documents réglementaires en vue d’une étude de première application chez l’homme (FIH), qui dépassera le cadre de ce projet.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Centre
Federal Riding (French)
Edmonton-Centre
Federal Riding Number
48014
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
776889289
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
PulseMedica Corp.
Recipient Operating Name
PulseMedica
Recipient Postal Code
T5N 3M3
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2025-2026-Q2-1034494
